NICE guidance updates on statins and secondary prevention

Draft guidance on statins

The National Institute for Health and Care Excellence (NICE) is recommending that the threshold for starting statins for the preventive treatment of cardiovascular disease (CVD) is halved from a 20% risk of developing CVD over 10 years to a 10% risk. This draft guidance – an update on its 2008 lipid modification guidance – follows new evidence for CVD risk assessment tools and the availability of generic statins.

Pay to access this premium content £5

The BJC is introducing a small charge for some of its premium content. On purchase you will receive an email to access the article and have a downloadable PDF to keep. The PDF can be downloaded from a button on the sidebar. Please note the purchase of this article is for your personal use only.
By supporting us in this way, you are helping us to deliver high-quality services to healthcare professionals. We will continue to keep the majority of our content free of charge.

You can access this article without logging in.
But don't miss out on the many Benefits of our Membership. Register Now.
Already a member? Login Now.